LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 300 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.62 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,111,000 | +150.8% | 8,162 | +123.5% | 0.02% | +122.2% |
| Q2 2017 | $443,000 | -78.8% | 3,652 | -81.1% | 0.01% | -94.4% |
| Q4 2015 | $2,092,000 | +484.4% | 19,293 | +362.2% | 0.16% | +184.2% |
| Q3 2015 | $358,000 | -92.5% | 4,174 | -91.2% | 0.06% | -70.0% |
| Q2 2015 | $4,772,000 | – | 47,295 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |